Bone mineral density in Addison's disease: Evidence for an effect of adrenal androgens on bone mass

98Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

It is unknown whether replacement doses of cortisone acetate and the absence of the small amounts of androgens secreted by the adrenal cortex may cause osteoporosis. This was studied in 35 patients (12 men and 23 women) suffering from primary adrenocortical failure and taking cortisone acetate 25-37.5 mg and fludrocortisone 50–100 ug daily. Bone mineral density was measured by single photon absorptiometry at the midshaft of the radius, representing cortical bone, and at the distal part of the radius, a site with a significant trabecular component. The bone mineral density was normal in premenopausal female patients as well as in male patients, showing that replacement doses of cortisone acetate do not affect bone mass. By contrast, in postmenopausal patients there was a dramatic bone loss. © 1987, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Devogelaer, J. P., Crabbe, J., & De Deuxchaisnes, C. N. (1987). Bone mineral density in Addison’s disease: Evidence for an effect of adrenal androgens on bone mass. British Medical Journal (Clinical Research Ed.), 294(6575), 798–800. https://doi.org/10.1136/bmj.294.6575.798

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free